Aquestive Therapeutics, Inc. (AQST) stock
AQSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.78+0.08 (+2.16%)
Close on Nov 18, 2026Market cap $474.43MP/E –Yield –
Aquestive Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Aquestive Therapeutics's market cap was $449.33M on Nov 11, 2026, against $753.06M a year earlier. Over the last 5 years it ranged from $26.63M to $785.91M, with a median of $260.58M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $449.33M | -42.8% |
| 2025 | Dec 31, 2025 | $785.91M | +142.1% |
| 2024 | Dec 31, 2024 | $324.59M | +140.8% |
| 2023 | Dec 29, 2023 | $134.82M | +177.5% |
| 2022 | Dec 30, 2022 | $48.58M | -68.8% |
| 2021 | Dec 31, 2021 | $155.92M | -13.3% |
| 2020 | Dec 31, 2020 | $179.87M | +23.4% |
| 2019 | Dec 31, 2019 | $145.75M | -7.2% |
| 2018 | Dec 31, 2018 | $157.14M | – |
See a number that looks wrong?